5 completed. 5 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 5 |
Follow Fumarates: new trials by email Literature Review of Fumarates trials Research Report on Fumarates
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Compare the Efficacy of Guselkumab to Fumaric Acid Esters for the Treatment of Participants With Moderate to Severe Plaque Psoriasis Guselkumab, Fumaric Acid Esters - Psoriasis | Phase 3 | Completed | Janssen-Cilag G.m.b.H | 119 | 2016-12-12 | 2020-02-28 |
| A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis Naive to Systemic Treatment Fumaric Acid Esters, Methotrexate, Ixekizumab - Plaque Psoriasis | Phase 3 | Completed | Eli Lilly and Company | 162 | 2016-01-20 | 2019-10-09 |
| Study of Secukinumab Compared to Fumaderm® in Adults With Moderate to Severe Psoriasis. Secukinumab, Fumaric acid - Psoriasis | Phase 3 | Completed | Novartis Pharmaceuticals | 202 | 2015-04-01 | 2017-10-27 |
| Effect of Aspirin Pretreatment or Slow Dose Titration on Flushing and Gastrointestinal Events in Healthy Volunteers Receiving Delayed-release Dimethyl Fumarate BG00012 (dimethyl fumarate), BG00012 placebo, ASA - Healthy | Phase 3 | Completed | Biogen | 173 | 2012-04-01 | 2016-06-13 |
| Fumaric Acid Versus Fumaric Acid Plus Narrow Band Type B Ultraviolet (UVB) for Psoriasis Full Body UV Therapy System UV 7002 plus fumaric acid esters, Fumaric acid esters - Plaque Psoriasis | Phase 3 | Completed | Medical University of Vienna | 30 | 2011-04-01 | 2014-05-12 |
Psoriasis (2)
Biogen (1) · Eli Lilly and Company (1) · Janssen-Cilag G.m.b.H (1) · Medical University of Vienna (1) · Novartis Pharmaceuticals (1)
Germany (3) · Austria (1) · United States (1)
2015 (1), 2016 (1)